Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Manuel E. Ruidiaz"'
Autor:
Manuel E. Ruidiaz, Andrew C. Kummel, Sarah L. Blair, Sergio Sandoval, Farnaz Hasteh, Maria Jose Cortes-Mateos, Joshua G. Vose, Anne M. Wallace, Jessica Wang-Rodriguez, David C. Martin
Publikováno v:
Journal of Surgical Oncology. 104:746-754
Background: This study is the first to examine in vivo the effect of thermal injury in breast conservation pathology in a direct comparison of traditional electrosurgery and an alternative low-thermal-injury device. Methods: A prospective study of 20
Autor:
Maria Jose Cortes-Mateos, Manuel E. Ruidiaz, Sergio Sandoval, Sarah L. Blair, Jessica Wang-Rodriguez, Casey N. Ta, Andrew C. Kummel, Davorka Messmer, David C. Martin
Publikováno v:
Acta Cytologica. 55:271-280
Objective: To develop an intraoperative method for margin status evaluation during breast conservation therapy (BCT) using an automated analysis of imprint cytology specimens. Study Design: Imprint cytology samples were prospectively taken from 47 pa
Autor:
Tambet Teesalu, Kazuki N. Sugahara, Pedro Aza-Blanc, Gary B. Braun, Hong Bo Pang, Manuel E. Ruidiaz, Tomas Friman, Erkki Ruoslahti
Publikováno v:
Nature communications
Neuropilins (NRPs) are trans-membrane receptors involved in axon guidance and vascular development. Many growth factors and other signalling molecules bind to NRPs through a carboxy (C)-terminal, basic sequence motif (C-end Rule or CendR motif). Pept
Publikováno v:
ISRN Surgery
Background.Breast conservation therapy (BCT) is the standard treatment for breast cancer; however, 32–63% of procedures have a positive margin leading to secondary procedures. The standard of care to evaluate surgical margins is based on permanent
Autor:
Joshua G. Vose, Howard L. Rosenberg, Eric J. Huang, Manuel E. Ruidiaz, Andrew C. Kummel, Davorka Messmer, Dominique Y. Atmodjo, Geoffrey C. Gurtner
Publikováno v:
Plastic and reconstructive surgery. 128(1)
BACKGROUND The authors investigated thermal injury depth, inflammation, and scarring in human abdominal skin by comparing the histology of incisions made with a standard "cold" scalpel blade, conventional electrosurgery, and the PEAK PlasmaBlade, a n
Autor:
Manuel E, Ruidiaz, Maria J, Cortes-Mateos, Sergio, Sandoval, David T, Martin, Jessica, Wang-Rodriguez, Farnaz, Hasteh, Anne, Wallace, Joshua G, Vose, Andrew C, Kummel, Sarah L, Blair
Publikováno v:
Journal of surgical oncology. 104(7)
This study is the first to examine in vivo the effect of thermal injury in breast conservation pathology in a direct comparison of traditional electrosurgery and an alternative low-thermal-injury device.A prospective study of 20 consecutive subjects
Publikováno v:
MRS Proceedings. 1346
Monoclonal antibodies are increasingly used in the treatment of cancer due to their enhanced targeting and immune system stimulation properties. Dosage guidelines typically do not account for personal cancer load or metabolism, thereby possibly affec
Autor:
Sarah L. Blair, Maria Jose Cortes-Mateos, Manuel E. Ruidiaz, Sergio Sandoval, William C. Trogler, Jessica Wang-Rodriguez, Davorka Messmer, David C. Martin, Andrew C. Kummel
Publikováno v:
Annals of Surgical Oncology. 16
Breast conservation therapy is the standard treatment for breast cancer; however, 20-50% of operations have a positive margin leading to secondary procedures. The standard of care to evaluate surgical margins is based on permanent section. Imprint cy
Autor:
Manuel E. Ruidiaz, Andrew C. Kummel, Ivan K. Schuller, Corneliu N. Colesniuc, Forest I. Bohrer, William C. Trogler, Jeongwon Park
Publikováno v:
Journal of the American Chemical Society. 131(2)
The sensitivities of metallophthalocyanine (MPcs: M = Co, Ni, Cu, Zn, and H(2)) chemiresistors to vapor phase electron donors were examined using 50 nm MPc films deposited on interdigitated electrodes. Sensor responses were measured as changes in cur
Autor:
Hong Bo Pang, Gary B. Braun, Manuel E. Ruidiaz, Erkki Ruoslahti, Kazuki N. Sugahara, Pedro Aza-Blanc, Tambet Teesalu, Tomas Friman
Publikováno v:
Cancer Research. 75:NG03-NG03
A major limiting factor in the development of cancer therapy, especially for solid tumors, is the delivery of therapeutic agents into target cells in vivo to reach the site of action. Major barriers to the efficient delivery of drugs, especially macr